<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>Assistant Professor, Stanford University Dept. of Chemistry and Sarafan ChEM-H | Chemical biology, synthetic biology | Small molecules, large molecules, biological mechanisms</description><link>https://bsky.app/profile/stevenbanik.bsky.social</link><title>@stevenbanik.bsky.social - Steven Banik</title><item><link>https://bsky.app/profile/stevenbanik.bsky.social/post/3mdxv5b7zmc24</link><description>Excited to share our latest preprint on work led by postdoc Robert Lusi (@rflusi.bsky.social)! Introducing ALTER (AGO-Led Targeted Editing of RNA) for non-downregulatory RNA manipulation by repurposing  hAGO2, non-immunogenic and capitalizing on evolution. https://www.biorxiv.org/content/10.64898/2026.02.01.703109v1</description><pubDate>03 Feb 2026 17:29 +0000</pubDate><guid isPermaLink="false">at://did:plc:ulhd7ccheqkwebsbksswsys7/app.bsky.feed.post/3mdxv5b7zmc24</guid></item><item><link>https://bsky.app/profile/stevenbanik.bsky.social/post/3m25keuatu52q</link><description>Really cool approach to an impactful problem from @greenahn.bsky.social @uwproteindesign.bsky.social!&#xA;&#xA;[contains quote post or other embedded content]</description><pubDate>01 Oct 2025 17:20 +0000</pubDate><guid isPermaLink="false">at://did:plc:ulhd7ccheqkwebsbksswsys7/app.bsky.feed.post/3m25keuatu52q</guid></item><item><link>https://bsky.app/profile/stevenbanik.bsky.social/post/3lqdpbktjrc2w</link><description>Incredibly proud of @christineisadora.bsky.social for defending her PhD work today! The first PhD from the Banik lab, and an amazing story on targeted protein relocalization and TRAMs! Her PhD work spans small molecules, neurobiology, cell engineering, and computational method development.</description><pubDate>29 May 2025 21:52 +0000</pubDate><guid isPermaLink="false">at://did:plc:ulhd7ccheqkwebsbksswsys7/app.bsky.feed.post/3lqdpbktjrc2w</guid></item><item><link>https://bsky.app/profile/stevenbanik.bsky.social/post/3lfn7slprrc2t</link><description>Amazing to see the LYTAC technology get to this point, catalytic extracellular degraders could open many new therapeutic opportunities or perhaps even become standard of care compared to antagonistic antibodies alone. Congrats to Lycia Tx!&#xA;&#xA;[contains quote post or other embedded content]</description><pubDate>13 Jan 2025 17:04 +0000</pubDate><guid isPermaLink="false">at://did:plc:ulhd7ccheqkwebsbksswsys7/app.bsky.feed.post/3lfn7slprrc2t</guid></item></channel></rss>